Research Explores Neurocognitive Profile, Cognitive Impairment in MDD
A literature review provided new insight into the clinical neurocognitive profile in major depressive disorder (MDD) and its relationship to cognitive deficits.
Personalizing rTMS Parameters For Depression Treatment Using Multimodal Neuroimaging
Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD).
Neuromodulation Therapy May Improve Treatment-Resistant Depression
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.
Left Dorsolateral Prefrontal Cortex rTMS in Alleviating MTBI Related Headaches and Depressive Symptoms
Persistent mild traumatic brain injury related headache (MTBI-HA) represents a neuropathic pain state.
The Implications of COVID-19 for Mental Health and Substance Abuse
The COVID-19 pandemic and the resulting economic recession have negatively affected many people’s mental health.
What Does the Future of the Mental Health Pandemic Hold?
Health experts across the country agree: we are in the midst of a mental health pandemic and have good reason to believe that this mental health crisis will lead to increased cases of depression throughout the year.
TTU Using TMS to Treat Depression
For some people, medication for depression doesn’t work and Transcranial Magnetic Stimulation, or TMS is helpful for patients that have exhausted every other option.
Year in Review: Major Depressive Disorder
The COVID-19 pandemic shined spotlight on rise of depression nationwide.
Transcranial Magnetic Stimulation (TMS)
Thousands of patients with depression in dozens of studies have shown that rTMS is safe and effective.